University Of Iowa Health Care First To Adopt Landmark FDA Approved AI Device In Diabetes Setting

The University of Iowa Health Care (UIHC) recently became the first U.S. health system to implement IDx-DR in the diabetes care setting. IDx-DR is a a U.S. Food & Drug Administration (FDA) approved artificial intelligence (AI) device that automatically detects more than mild diabetic retinopathy in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy.

In April, IDx-DR—which is developed by IDx—became the first medical device to be approved by the FDA for screening decisions without requiring a specialist to interpret the results. Diabatic retinopathy occurs when blood sugar . . .